Cargando…
Low background and high contrast PET imaging of amyloid-β with [(11)C]AZD2995 and [(11)C]AZD2184 in Alzheimer’s disease patients
PURPOSE: The aim of this study was to evaluate AZD2995 side by side with AZD2184 as novel PET radioligands for imaging of amyloid-β in Alzheimer’s disease (AD). METHODS: In vitro binding of tritium-labelled AZD2995 and AZD2184 was studied and compared with that of the established amyloid-β PET radio...
Autores principales: | Forsberg, Anton, Juréus, Anders, Cselényi, Zsolt, Eriksdotter, Maria, Freund-Levi, Yvonne, Jeppsson, Fredrik, Swahn, Britt-Marie, Sandell, Johan, Julin, Per, Schou, Magnus, Andersson, Jan, Johnström, Peter, Varnäs, Katarina, Halldin, Christer, Farde, Lars, Svensson, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590405/ https://www.ncbi.nlm.nih.gov/pubmed/23324871 http://dx.doi.org/10.1007/s00259-012-2322-6 |
Ejemplares similares
-
Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
por: Nyberg, Svante, et al.
Publicado: (2009) -
Synthesis, Biodistribution, and Radiation Dosimetry
of a Novel mGluR5 Radioligand: (18)F-AZD9272
por: Nag, Sangram, et al.
Publicado: (2020) -
Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012) -
PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018) -
Quantification and reliability of [(11)C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects
por: Cselényi, Zsolt, et al.
Publicado: (2020)